Oppenheimer Reiterates Market Perform Rating for Pliant Therapeutics (NASDAQ:PLRX)
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports. A number of other equities research analysts also recently issued reports on the stock. Wells Fargo & Company downgraded shares of Pliant Therapeutics from an “overweight” […]
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports. A number of other equities research analysts also recently issued reports on the stock. Wells Fargo & Company downgraded shares of Pliant Therapeutics from an “overweight” […]
